{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:26:59Z","timestamp":1782808019822,"version":"3.54.5"},"publisher-location":"Cham","reference-count":199,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030336783","type":"print"},{"value":"9783030336790","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_303","type":"book-chapter","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T07:03:00Z","timestamp":1584601380000},"page":"299-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes"],"prefix":"10.1007","author":[{"given":"Paul S.","family":"Regier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle M.","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rose","family":"Childress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"303_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.addbeh.2013.10.019","volume":"39","author":"RR Abdalla","year":"2014","unstructured":"Abdalla RR, Madruga CS, Ribeiro M et al (2014) Prevalence of cocaine use in Brazil: data from the II Brazilian national alcohol and drugs survey (BNADS). Addict Behav 39:297\u2013301","journal-title":"Addict Behav"},{"key":"303_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnins.2014.00140","volume":"8","author":"R Agabio","year":"2014","unstructured":"Agabio R, Colombo G (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8:140. https:\/\/doi.org\/10.3389\/fnins.2014.00140","journal-title":"Front Neurosci"},{"key":"303_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10550490802545174","volume":"18","author":"J Ahmadi","year":"2009","unstructured":"Ahmadi J, Kampman KM, Oslin DM et al (2009) Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am J Addict 18:81\u201386. https:\/\/doi.org\/10.1080\/10550490802545174","journal-title":"Am J Addict"},{"key":"303_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neubiorev.2010.04.005","volume":"35","author":"SH Ahmed","year":"2010","unstructured":"Ahmed SH (2010) Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction. Neurosci Biobehav Rev 35:172\u2013184. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.04.005","journal-title":"Neurosci Biobehav Rev"},{"key":"303_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1126\/science.282.5387.298","volume":"282","author":"SH Ahmed","year":"1998","unstructured":"Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298\u2013300. https:\/\/doi.org\/10.1126\/science.282.5387.298","journal-title":"Science"},{"key":"303_CR6","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1038\/npp.2013.151","volume":"38","author":"R Al-Hasani","year":"2013","unstructured":"Al-Hasani R, McCall JG, Foshage AM, Bruchas MR (2013) Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism. Neuropsychopharmacology 38:2484\u20132497. https:\/\/doi.org\/10.1038\/npp.2013.151","journal-title":"Neuropsychopharmacology"},{"key":"303_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nn2054","volume":"11","author":"SM Anderson","year":"2008","unstructured":"Anderson SM, Famous KR, Sadri-Vakili G et al (2008) CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci 11:344\u2013353. https:\/\/doi.org\/10.1038\/nn2054","journal-title":"Nat Neurosci"},{"key":"303_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","volume":"104","author":"AL Anderson","year":"2009","unstructured":"Anderson AL, Reid MS, Li S-H et al (2009) Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend 104:133\u2013139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.04.015","journal-title":"Drug Alcohol Depend"},{"key":"303_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","volume":"74","author":"AH Ashok","year":"2017","unstructured":"Ashok AH, Mizuno Y, Volkow ND, Howes OD (2017) Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis. JAMA Psychiat 74:511\u2013519. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0135","journal-title":"JAMA Psychiat"},{"key":"303_CR10","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/npp.2017.53","volume":"42","author":"E Augier","year":"2017","unstructured":"Augier E, Dulman RS, Damadzic R et al (2017) The GABAB positive allosteric modulator ADX71441 attenuates alcohol self-administration and relapse to alcohol seeking in rats. Neuropsychopharmacology 42:1789\u20131799. https:\/\/doi.org\/10.1038\/npp.2017.53","journal-title":"Neuropsychopharmacology"},{"key":"303_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4088\/JCP.14m09377","volume":"77","author":"L Balda\u00e7ara","year":"2016","unstructured":"Balda\u00e7ara L, Cogo-Moreira H, Parreira BL et al (2016) Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 77:398\u2013406. https:\/\/doi.org\/10.4088\/JCP.14m09377","journal-title":"J Clin Psychiatry"},{"key":"303_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(94)91229-7","volume":"637","author":"TJ Bazzett","year":"1994","unstructured":"Bazzett TJ, Becker JB (1994) Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Res 637:163\u2013172. https:\/\/doi.org\/10.1016\/0006-8993(94)91229-7","journal-title":"Brain Res"},{"key":"303_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/syn.890050211","volume":"5","author":"JB Becker","year":"1990","unstructured":"Becker JB (1990) Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release. Synapse 5:157\u2013164. https:\/\/doi.org\/10.1002\/syn.890050211","journal-title":"Synapse"},{"key":"303_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s0091-3057(99)00168-9","volume":"64","author":"JB Becker","year":"1999","unstructured":"Becker JB (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64:803\u2013812. https:\/\/doi.org\/10.1016\/s0091-3057(99)00168-9","journal-title":"Pharmacol Biochem Behav"},{"key":"303_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31887\/DCNS.2016.18.4\/jbecker","volume":"18","author":"JB Becker","year":"2016","unstructured":"Becker JB (2016) Sex differences in addiction. Dialogues Clin Neurosci 18:395\u2013402","journal-title":"Dialogues Clin Neurosci"},{"key":"303_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","volume":"28","author":"KC Berridge","year":"1998","unstructured":"Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28:309\u2013369. https:\/\/doi.org\/10.1016\/S0165-0173(98)00019-8","journal-title":"Brain Res Rev"},{"key":"303_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.expneurol.2014.01.022","volume":"259","author":"SAM Bobzean","year":"2014","unstructured":"Bobzean SAM, DeNobrega AK, Perrotti LI (2014) Sex differences in the neurobiology of drug addiction. Exp Neurol 259:64\u201374. https:\/\/doi.org\/10.1016\/j.expneurol.2014.01.022","journal-title":"Exp Neurol"},{"key":"303_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0893-133X(01)00371-2","volume":"26","author":"KR Bonson","year":"2002","unstructured":"Bonson KR, Grant SJ, Contoreggi CS et al (2002) Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26:376\u2013386. https:\/\/doi.org\/10.1016\/S0893-133X(01)00371-2","journal-title":"Neuropsychopharmacology"},{"key":"303_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s002130050056","volume":"148","author":"K Brebner","year":"2000","unstructured":"Brebner K, Phelan R, Roberts DC (2000a) Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology (Berl) 148:314\u2013321","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0091-3057(00)00286-0","volume":"66","author":"K Brebner","year":"2000","unstructured":"Brebner K, Phelan R, Roberts DC (2000b) Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 66:857\u2013862","journal-title":"Pharmacol Biochem Behav"},{"key":"303_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/syn.10278","volume":"50","author":"JD Brodie","year":"2003","unstructured":"Brodie JD, Figueroa E, Dewey SL (2003) Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse 50:261\u2013265. https:\/\/doi.org\/10.1002\/syn.10278","journal-title":"Synapse"},{"key":"303_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/syn.20097","volume":"55","author":"JD Brodie","year":"2005","unstructured":"Brodie JD, Figueroa E, Laska EM, Dewey SL (2005) Safety and efficacy of \u03b3-vinyl GABA (GVG) for the treatment of methamphetamine and\/or cocaine addiction. Synapse 55:122\u2013125. https:\/\/doi.org\/10.1002\/syn.20097","journal-title":"Synapse"},{"key":"303_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1176\/appi.ajp.2009.08121811","volume":"166","author":"JD Brodie","year":"2009","unstructured":"Brodie JD, Case BG, Figueroa E et al (2009) Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees. Am J Psychiatry 166:1269\u20131277. https:\/\/doi.org\/10.1176\/appi.ajp.2009.08121811","journal-title":"Am J Psychiatry"},{"key":"303_CR24","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.2174\/156802606778522131","volume":"6","author":"MJ Bubar","year":"2006","unstructured":"Bubar MJ, Cunningham KA (2006) Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971\u20131985","journal-title":"Curr Top Med Chem"},{"key":"303_CR25","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.1523\/JNEUROSCI.1033-13.2013","volume":"33","author":"ES Calipari","year":"2013","unstructured":"Calipari ES, Ferris MJ (2013) Amphetamine mechanisms and actions at the dopamine terminal revisited. J Neurosci 33:8923\u20138925. https:\/\/doi.org\/10.1523\/JNEUROSCI.1033-13.2013","journal-title":"J Neurosci"},{"key":"303_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s002130050937","volume":"143","author":"UC Campbell","year":"1999","unstructured":"Campbell UC, Lac ST, Carroll ME (1999) Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology (Berl) 143:209\u2013214","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2016.03.040","volume":"780","author":"D-N Cao","year":"2016","unstructured":"Cao D-N, Shi J-J, Hao W et al (2016) Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction. Eur J Pharmacol 780:129\u2013135. https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.040","journal-title":"Eur J Pharmacol"},{"key":"303_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2007.05.007","volume":"569","author":"AN Carey","year":"2007","unstructured":"Carey AN, Borozny K, Aldrich JV, McLaughlin JP (2007) Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur J Pharmacol 569:84\u201389. https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.007","journal-title":"Eur J Pharmacol"},{"key":"303_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/HRP.0000000000000122","volume":"25","author":"P-J Carpentier","year":"2017","unstructured":"Carpentier P-J, Levin FR (2017) Pharmacological treatment of ADHD in addicted patients: what does the literature tell us? Harv Rev Psychiatry 25:50\u201364. https:\/\/doi.org\/10.1097\/HRP.0000000000000122","journal-title":"Harv Rev Psychiatry"},{"key":"303_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10826084.2011.521069","volume":"46","author":"KM Carroll","year":"2011","unstructured":"Carroll KM, Kiluk BD, Nich C et al (2011) Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse 46:23\u201334. https:\/\/doi.org\/10.3109\/10826084.2011.521069","journal-title":"Subst Use Misuse"},{"key":"303_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1037\/0022-006X.72.4.712","volume":"72","author":"A Cepeda-Benito","year":"2004","unstructured":"Cepeda-Benito A, Reynoso JT, Erath S (2004) Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 72:712\u2013722. https:\/\/doi.org\/10.1037\/0022-006X.72.4.712","journal-title":"J Consult Clin Psychol"},{"key":"303_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/10550490601184225","volume":"16","author":"DA Charney","year":"2007","unstructured":"Charney DA, Palacios-Boix J, Gill KJ (2007) Sexual abuse and the outcome of addiction treatment. Am J Addict 16:93\u2013100. https:\/\/doi.org\/10.1080\/10550490601184225","journal-title":"Am J Addict"},{"key":"303_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopsych.2011.05.025","volume":"70","author":"HW Chase","year":"2011","unstructured":"Chase HW, Eickhoff SB, Laird AR, Hogarth L (2011) The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biol Psychiatry 70:785\u2013793. https:\/\/doi.org\/10.1016\/j.biopsych.2011.05.025","journal-title":"Biol Psychiatry"},{"key":"303_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tips.2016.09.006","volume":"38","author":"MJ Chenoweth","year":"2017","unstructured":"Chenoweth MJ, Tyndale RF (2017) Pharmacogenetic optimization of smoking cessation treatment. Trends Pharmacol Sci 38:55\u201366. https:\/\/doi.org\/10.1016\/j.tips.2016.09.006","journal-title":"Trends Pharmacol Sci"},{"key":"303_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.1197410","volume":"330","author":"EYT Chien","year":"2010","unstructured":"Chien EYT, Liu W, Zhao Q et al (2010) Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist. Science 330:1091\u20131095. https:\/\/doi.org\/10.1126\/science.1197410","journal-title":"Science"},{"key":"303_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1176\/ajp.156.1.11","volume":"156","author":"AR Childress","year":"1999","unstructured":"Childress AR, Mozley PD, McElgin W et al (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11\u201318. https:\/\/doi.org\/10.1176\/ajp.156.1.11","journal-title":"Am J Psychiatry"},{"key":"303_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-008-1222-8","volume":"200","author":"KA Chiodo","year":"2008","unstructured":"Chiodo KA, L\u00e4ck CM, Roberts DCS (2008) Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology (Berl) 200:465\u2013473. https:\/\/doi.org\/10.1007\/s00213-008-1222-8","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/YCO.0000000000000168","volume":"28","author":"C Chomchai","year":"2015","unstructured":"Chomchai C, Chomchai S (2015) Global patterns of methamphetamine use. Curr Opin Psychiatry 28:269. https:\/\/doi.org\/10.1097\/YCO.0000000000000168","journal-title":"Curr Opin Psychiatry"},{"key":"303_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.eplepsyres.2013.02.014","volume":"105","author":"LM Clayton","year":"2013","unstructured":"Clayton LM, Stern WM, Newman WD et al (2013) Evolution of visual field loss over ten years in individuals taking vigabatrin. Epilepsy Res 105:262\u2013271. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.02.014","journal-title":"Epilepsy Res"},{"key":"303_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.drugalcdep.2011.08.007","volume":"121","author":"CG Connolly","year":"2012","unstructured":"Connolly CG, Foxe JJ, Nierenberg J et al (2012) The neurobiology of cognitive control in successful cocaine abstinence. Drug Alcohol Depend 121:45\u201353. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.08.007","journal-title":"Drug Alcohol Depend"},{"key":"303_CR41","doi-asserted-by":"publisher","first-page":"RC89","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","volume":"20","author":"JL Cornish","year":"2000","unstructured":"Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20:RC89. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-15-j0006.2000","journal-title":"J Neurosci"},{"key":"303_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/adb.12314","volume":"21","author":"KE Courtney","year":"2016","unstructured":"Courtney KE, Schacht JP, Hutchison K et al (2016) Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addict Biol 21:3\u201322. https:\/\/doi.org\/10.1111\/adb.12314","journal-title":"Addict Biol"},{"key":"303_CR43","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/npp.2013.99","volume":"38","author":"RC Crist","year":"2013","unstructured":"Crist RC, Clarke T-K, Ang A et al (2013) An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology 38:2003\u20132010. https:\/\/doi.org\/10.1038\/npp.2013.99","journal-title":"Neuropsychopharmacology"},{"key":"303_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/tpj.2016.89","volume":"18","author":"RC Crist","year":"2018","unstructured":"Crist RC, Doyle GA, Nelson EC et al (2018) A polymorphism in the OPRM1 3\u2032 untranslated region is associated with methadone efficacy in treating opioid dependence. Pharmacogenomics J 18:173\u2013179. https:\/\/doi.org\/10.1038\/tpj.2016.89","journal-title":"Pharmacogenomics J"},{"key":"303_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00213-010-1807-x","volume":"209","author":"PW Czoty","year":"2010","unstructured":"Czoty PW, Martelle JL, Nader MA (2010) Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology (Berl) 209:375\u2013382. https:\/\/doi.org\/10.1007\/s00213-010-1807-x","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1124\/jpet.113.204321","volume":"345","author":"PW Czoty","year":"2013","unstructured":"Czoty PW, Martelle SE, Gould RW, Nader MA (2013) Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys. J Pharmacol Exp Ther 345:374\u2013382. https:\/\/doi.org\/10.1124\/jpet.113.204321","journal-title":"J Pharmacol Exp Ther"},{"key":"303_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuroscience.2016.03.002","volume":"324","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Blough BE, Fennell TR et al (2016) Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys. Neuroscience 324:367\u2013376. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.03.002","journal-title":"Neuroscience"},{"key":"303_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0149-7634(85)90022-3","volume":"9","author":"CA Dackis","year":"1985","unstructured":"Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469\u2013477. https:\/\/doi.org\/10.1016\/0149-7634(85)90022-3","journal-title":"Neurosci Biobehav Rev"},{"key":"303_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1196\/annals.1300.021","volume":"1003","author":"C Dackis","year":"2003","unstructured":"Dackis C, O\u2019Brien C (2003) Glutamatergic agents for cocaine dependence. Ann N Y Acad Sci 1003:328\u2013345","journal-title":"Ann N Y Acad Sci"},{"key":"303_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","volume":"70","author":"CA Dackis","year":"2003","unstructured":"Dackis CA, Lynch KG, Yu E et al (2003) Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70:29\u201337. https:\/\/doi.org\/10.1016\/S0376-8716(02)00335-6","journal-title":"Drug Alcohol Depend"},{"key":"303_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.npp.1300600","volume":"30","author":"CA Dackis","year":"2005","unstructured":"Dackis CA, Kampman KM, Lynch KG et al (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30:205\u2013211. https:\/\/doi.org\/10.1038\/sj.npp.1300600","journal-title":"Neuropsychopharmacology"},{"key":"303_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","volume":"43","author":"CA Dackis","year":"2012","unstructured":"Dackis CA, Kampman KM, Lynch KG et al (2012) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat 43:303\u2013312. https:\/\/doi.org\/10.1016\/j.jsat.2011.12.014","journal-title":"J Subst Abuse Treat"},{"key":"303_CR53","doi-asserted-by":"publisher","first-page":"943","DOI":"10.15288\/jsad.2011.72.943","volume":"72","author":"AC Dean","year":"2011","unstructured":"Dean AC, Sevak RJ, Monterosso JR et al (2011) Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs 72:943\u2013953","journal-title":"J Stud Alcohol Drugs"},{"key":"303_CR54","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.1099020","volume":"305","author":"V Deroche-Gamonet","year":"2004","unstructured":"Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014\u20131017. https:\/\/doi.org\/10.1126\/science.1099020","journal-title":"Science"},{"key":"303_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugalcdep.2014.10.007","volume":"145","author":"EE DeVito","year":"2014","unstructured":"DeVito EE, Babuscio TA, Nich C et al (2014) Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram. Drug Alcohol Depend 145:156\u2013167. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.007","journal-title":"Drug Alcohol Depend"},{"key":"303_CR56","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1523\/JNEUROSCI.12-10-03773.1992","volume":"12","author":"SL Dewey","year":"1992","unstructured":"Dewey SL, Smith GS, Logan J et al (1992) GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci 12:3773\u20133780. https:\/\/doi.org\/10.1523\/JNEUROSCI.12-10-03773.1992","journal-title":"J Neurosci"},{"key":"303_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.coph.2006.11.003","volume":"7","author":"G Di Chiara","year":"2007","unstructured":"Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn\u2019t do. Curr Opin Pharmacol 7:69\u201376. https:\/\/doi.org\/10.1016\/j.coph.2006.11.003","journal-title":"Curr Opin Pharmacol"},{"key":"303_CR58","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.npp.1300088","volume":"28","author":"P Di Ciano","year":"2003","unstructured":"Di Ciano P, Everitt BJ (2003) The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28:510\u2013518. https:\/\/doi.org\/10.1038\/sj.npp.1300088","journal-title":"Neuropsychopharmacology"},{"key":"303_CR59","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrn.2017.113","volume":"18","author":"M Diana","year":"2017","unstructured":"Diana M, Raij T, Melis M et al (2017) Rehabilitating the addicted brain with transcranial magnetic stimulation. Nat Rev Neurosci 18:685\u2013693. https:\/\/doi.org\/10.1038\/nrn.2017.113","journal-title":"Nat Rev Neurosci"},{"key":"303_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0376-8716(00)00137-X","volume":"62","author":"RN Ehrman","year":"2001","unstructured":"Ehrman RN, Robbins SJ, Cornish JW (2001) Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend 62:1\u20137","journal-title":"Drug Alcohol Depend"},{"key":"303_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1212\/CPJ.0000000000000316","volume":"7","author":"AJ Espay","year":"2017","unstructured":"Espay AJ, Pagan FL, Walter BL et al (2017) Optimizing extended-release carbidopa\/levodopa in Parkinson disease: consensus on conversion from standard therapy. Neurol Clin Pract 7:86\u201393. https:\/\/doi.org\/10.1212\/CPJ.0000000000000316","journal-title":"Neurol Clin Pract"},{"key":"303_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/syn.10238","volume":"50","author":"P Fadda","year":"2003","unstructured":"Fadda P, Scherma M, Fresu A et al (2003) Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50:1\u20136. https:\/\/doi.org\/10.1002\/syn.10238","journal-title":"Synapse"},{"key":"303_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","volume":"14","author":"VJ Felitti","year":"1998","unstructured":"Felitti VJ, Anda RF, Nordenberg D et al (1998) Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. Am J Prev Med 14:245\u2013258. https:\/\/doi.org\/10.1016\/S0749-3797(98)00017-8","journal-title":"Am J Prev Med"},{"key":"303_CR64","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/adb.12388","volume":"22","author":"J-MN Ferland","year":"2017","unstructured":"Ferland J-MN, Winstanley CA (2017) Risk-preferring rats make worse decisions and show increased incubation of craving after cocaine self-administration. Addict Biol 22:991\u20131001. https:\/\/doi.org\/10.1111\/adb.12388","journal-title":"Addict Biol"},{"key":"303_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2014.06.016","volume":"88","author":"M Filip","year":"2015","unstructured":"Filip M, Frankowska M, Sadakierska-Chudy A et al (2015) GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Neuropharmacology 88:36\u201347. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.016","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"303_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuropharm.2008.06.027","volume":"56","author":"SB Flagel","year":"2009","unstructured":"Flagel SB, Akil H, Robinson TE (2009) Individual differences in the attribution of incentive salience to reward-related cues: implications for addiction. Neuropharmacology 56(Suppl 1):139\u2013148. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.027","journal-title":"Neuropharmacology"},{"key":"303_CR67","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/npp.2009.142","volume":"35","author":"SB Flagel","year":"2010","unstructured":"Flagel SB, Robinson TE, Clark JJ et al (2010) An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: implications for addiction. Neuropsychopharmacology 35:388\u2013400. https:\/\/doi.org\/10.1038\/npp.2009.142","journal-title":"Neuropsychopharmacology"},{"key":"303_CR68","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/npp.2013.77","volume":"38","author":"A Fotros","year":"2013","unstructured":"Fotros A, Casey KF, Larcher K et al (2013) Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [18F]fallypride study in cocaine dependent participants. Neuropsychopharmacology 38:1780\u20131788. https:\/\/doi.org\/10.1038\/npp.2013.77","journal-title":"Neuropsychopharmacology"},{"key":"303_CR69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-12-420118-7.00006-8","volume":"69","author":"H Fox","year":"2014","unstructured":"Fox H, Sinha R (2014) The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. Adv Pharmacol 69:217\u2013265. https:\/\/doi.org\/10.1016\/B978-0-12-420118-7.00006-8","journal-title":"Adv Pharmacol"},{"key":"303_CR70","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/npp.2014.1","volume":"39","author":"HC Fox","year":"2014","unstructured":"Fox HC, Morgan PT, Sinha R (2014) Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals. Neuropsychopharmacology 39:1527\u20131537. https:\/\/doi.org\/10.1038\/npp.2014.1","journal-title":"Neuropsychopharmacology"},{"key":"303_CR71","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/sj.npp.1301371","volume":"32","author":"TR Franklin","year":"2007","unstructured":"Franklin TR, Wang Z, Wang J et al (2007) Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 32:2301\u20132309. https:\/\/doi.org\/10.1038\/sj.npp.1301371","journal-title":"Neuropsychopharmacology"},{"key":"303_CR72","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/npp.2008.124","volume":"34","author":"TR Franklin","year":"2008","unstructured":"Franklin TR, Lohoff FW, Wang Z et al (2008) DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 34:717\u2013728. https:\/\/doi.org\/10.1038\/npp.2008.124","journal-title":"Neuropsychopharmacology"},{"key":"303_CR73","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-2999(01)00800-7","volume":"414","author":"MR Gerasimov","year":"2001","unstructured":"Gerasimov MR, Schiffer WK, Gardner EL et al (2001) GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine. Eur J Pharmacol 414:205\u2013209","journal-title":"Eur J Pharmacol"},{"key":"303_CR74","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.euroneuro.2003.08.004","volume":"13","author":"NE Goeders","year":"2003","unstructured":"Goeders NE (2003) The impact of stress on addiction. Eur Neuropsychopharmacol 13:435\u2013441. https:\/\/doi.org\/10.1016\/j.euroneuro.2003.08.004","journal-title":"Eur Neuropsychopharmacol"},{"key":"303_CR75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/ADM.0b013e318273863a","volume":"7","author":"M Goldman","year":"2013","unstructured":"Goldman M, Szucs-Reed RP, Jagannathan K et al (2013) Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects. J Addict Med 7:8\u201316. https:\/\/doi.org\/10.1097\/ADM.0b013e318273863a","journal-title":"J Addict Med"},{"key":"303_CR76","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","volume":"159","author":"RZ Goldstein","year":"2002","unstructured":"Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642\u20131652","journal-title":"Am J Psychiatry"},{"key":"303_CR77","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein RZ, Volkow ND (2011) Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12:652\u2013669. https:\/\/doi.org\/10.1038\/nrn3119","journal-title":"Nat Rev Neurosci"},{"key":"303_CR78","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","volume":"21","author":"J Grabowski","year":"2001","unstructured":"Grabowski J, Rhoades H, Schmitz J et al (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21:522","journal-title":"J Clin Psychopharmacol"},{"key":"303_CR79","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/sj.npp.1300392","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Rhoades H, Stotts A et al (2004) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29:969\u2013981. https:\/\/doi.org\/10.1038\/sj.npp.1300392","journal-title":"Neuropsychopharmacology"},{"key":"303_CR80","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ynstr.2018.08.003","volume":"9","author":"MK Greenwald","year":"2018","unstructured":"Greenwald MK (2018) Anti-stress neuropharmacological mechanisms and targets for addiction treatment: a translational framework. Neurobiol Stress 9:84\u2013104. https:\/\/doi.org\/10.1016\/j.ynstr.2018.08.003","journal-title":"Neurobiol Stress"},{"key":"303_CR81","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2010.175","volume":"35","author":"MK Greenwald","year":"2010","unstructured":"Greenwald MK, Lundahl LH, Steinmiller CL (2010) Sustained release d-amphetamine reduces cocaine but not \u2018speedball\u2019-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine\/heroin polydrug abusers. Neuropsychopharmacology 35:2624\u20132637. https:\/\/doi.org\/10.1038\/npp.2010.175","journal-title":"Neuropsychopharmacology"},{"key":"303_CR82","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brainres.2015.02.053","volume":"1628","author":"CA Hanlon","year":"2015","unstructured":"Hanlon CA, Dowdle LT, Austelle CW et al (2015) What goes up, can come down: novel brain stimulation paradigms may attenuate craving and craving-related neural circuitry in substance dependent individuals. Brain Res 1628:199\u2013209. https:\/\/doi.org\/10.1016\/j.brainres.2015.02.053","journal-title":"Brain Res"},{"key":"303_CR83","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.npp.1301472","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL, Haney M, Vosburg SK et al (2008) Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33:761\u2013768. https:\/\/doi.org\/10.1038\/sj.npp.1301472","journal-title":"Neuropsychopharmacology"},{"key":"303_CR84","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/14760584.2017.1378577","volume":"16","author":"RD Heekin","year":"2017","unstructured":"Heekin RD, Shorter D, Kosten TR (2017) Current status and future prospects for the development of substance abuse vaccines. Expert Rev Vaccines 16:1067\u20131077. https:\/\/doi.org\/10.1080\/14760584.2017.1378577","journal-title":"Expert Rev Vaccines"},{"key":"303_CR85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","volume":"1187","author":"CA Heidbreder","year":"2010","unstructured":"Heidbreder CA, Newman AH (2010) Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann N Y Acad Sci 1187:4\u201334. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05149.x","journal-title":"Ann N Y Acad Sci"},{"key":"303_CR86","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrn3110","volume":"12","author":"M Heilig","year":"2011","unstructured":"Heilig M, Goldman D, Berrettini W, O\u2019Brien CP (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12:670\u2013684. https:\/\/doi.org\/10.1038\/nrn3110","journal-title":"Nat Rev Neurosci"},{"key":"303_CR87","doi-asserted-by":"publisher","first-page":"11017","DOI":"10.1523\/JNEUROSCI.3321-04.2004","volume":"24","author":"R Hester","year":"2004","unstructured":"Hester R, Garavan H (2004) Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24:11017\u201311022. https:\/\/doi.org\/10.1523\/JNEUROSCI.3321-04.2004","journal-title":"J Neurosci"},{"key":"303_CR88","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1037\/a0021791","volume":"18","author":"R Hester","year":"2010","unstructured":"Hester R, Lee N, Pennay A et al (2010) The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. Exp Clin Psychopharmacol 18:489\u2013497. https:\/\/doi.org\/10.1037\/a0021791","journal-title":"Exp Clin Psychopharmacol"},{"key":"303_CR89","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00213-013-3245-z","volume":"231","author":"LS Hwa","year":"2014","unstructured":"Hwa LS, Kalinichev M, Haddouk H et al (2014) Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Psychopharmacology (Berl) 231:333\u2013343. https:\/\/doi.org\/10.1007\/s00213-013-3245-z","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR90","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1037\/0893-164X.21.2.233","volume":"21","author":"SM Hyman","year":"2007","unstructured":"Hyman SM, Paliwal P, Sinha R (2007) Childhood maltreatment, perceived stress, and stress-related coping in recently abstinent cocaine dependent adults. Psychol Addict Behav 21:233. https:\/\/doi.org\/10.1037\/0893-164X.21.2.233","journal-title":"Psychol Addict Behav"},{"key":"303_CR91","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugalcdep.2007.08.006","volume":"92","author":"SM Hyman","year":"2008","unstructured":"Hyman SM, Paliwal P, Chaplin TM et al (2008) Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend 92:208\u2013216. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.08.006","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"303_CR92","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.biopsych.2018.07.022","volume":"85","author":"MH James","year":"2018","unstructured":"James MH, Stopper CM, Zimmer BA et al (2018) Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats. Biol Psychiatry 85(11):925\u2013935. https:\/\/doi.org\/10.1016\/j.biopsych.2018.07.022","journal-title":"Biol Psychiatry"},{"key":"303_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2013.10.013","volume":"38","author":"AJ Jasinska","year":"2014","unstructured":"Jasinska AJ, Stein EA, Kaiser J et al (2014) Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 38:1\u201316. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.10.013","journal-title":"Neurosci Biobehav Rev"},{"key":"303_CR94","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/PL00005483","volume":"146","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Taylor JR (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146:373\u2013390. https:\/\/doi.org\/10.1007\/PL00005483","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR95","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","volume":"70","author":"BA Johnson","year":"2013","unstructured":"Johnson BA, Ait-Daoud N, Wang X-Q et al (2013) Topiramate for the treatment of cocaine addiction: a randomized clinical trial. JAMA Psychiat 70:1338\u20131346. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2295","journal-title":"JAMA Psychiat"},{"key":"303_CR96","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1021\/acs.jpca.6b11770","volume":"121","author":"L Jones","year":"2017","unstructured":"Jones L, Lin L (2017) An in silico study on the isomers of pentacene: the case for air-stable and alternative C22H14 acenes for organic electronics. J Phys Chem A 121:2804\u20132813. https:\/\/doi.org\/10.1021\/acs.jpca.6b11770","journal-title":"J Phys Chem A"},{"key":"303_CR97","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/acer.12643","volume":"39","author":"JD Jones","year":"2015","unstructured":"Jones JD, Comer SD, Kranzler HR (2015) The pharmacogenetics of alcohol use disorder. Alcohol Clin Exp Res 39:391\u2013402. https:\/\/doi.org\/10.1111\/acer.12643","journal-title":"Alcohol Clin Exp Res"},{"key":"303_CR98","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1021\/jacs.7b10965","volume":"140","author":"JI Juncosa","year":"2018","unstructured":"Juncosa JI, Takaya K, Le HV et al (2018) Design and mechanism of (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, a highly potent \u03b3-aminobutyric acid aminotransferase inactivator for the treatment of addiction. J Am Chem Soc 140:2151\u20132164. https:\/\/doi.org\/10.1021\/jacs.7b10965","journal-title":"J Am Chem Soc"},{"key":"303_CR99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugalcdep.2009.03.011","volume":"103","author":"R Kahn","year":"2009","unstructured":"Kahn R, Biswas K, Childress A-R et al (2009) Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend 103:59\u201364. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.03.011","journal-title":"Drug Alcohol Depend"},{"key":"303_CR100","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1523\/JNEUROSCI.13-01-00266.1993","volume":"13","author":"PW Kalivas","year":"1993","unstructured":"Kalivas PW, Duffy P (1993a) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266\u2013275. https:\/\/doi.org\/10.1523\/JNEUROSCI.13-01-00266.1993","journal-title":"J Neurosci"},{"key":"303_CR101","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1523\/JNEUROSCI.13-01-00276.1993","volume":"13","author":"PW Kalivas","year":"1993","unstructured":"Kalivas PW, Duffy P (1993b) Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci 13:276\u2013284. https:\/\/doi.org\/10.1523\/JNEUROSCI.13-01-00276.1993","journal-title":"J Neurosci"},{"key":"303_CR102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1196\/annals.1300.009","volume":"1003","author":"PW Kalivas","year":"2003","unstructured":"Kalivas PW, McFarland K, Bowers S et al (2003) Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci 1003:169\u2013175. https:\/\/doi.org\/10.1196\/annals.1300.009","journal-title":"Ann N Y Acad Sci"},{"key":"303_CR103","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11920-010-0143-5","volume":"12","author":"KM Kampman","year":"2010","unstructured":"Kampman KM (2010) What\u2019s new in the treatment of cocaine addiction? Curr Psychiatry Rep 12:441\u2013447. https:\/\/doi.org\/10.1007\/s11920-010-0143-5","journal-title":"Curr Psychiatry Rep"},{"key":"303_CR104","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0306-4603(01)00171-X","volume":"27","author":"KM Kampman","year":"2002","unstructured":"Kampman KM, Volpicelli JR, Mulvaney F et al (2002) Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav 27:251\u2013260","journal-title":"Addict Behav"},{"key":"303_CR105","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","volume":"75","author":"KM Kampman","year":"2004","unstructured":"Kampman KM, Pettinati H, Lynch KG et al (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75:233\u2013240. https:\/\/doi.org\/10.1016\/j.drugalcdep.2004.03.008","journal-title":"Drug Alcohol Depend"},{"key":"303_CR106","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","volume":"133","author":"KM Kampman","year":"2013","unstructured":"Kampman KM, Pettinati HM, Lynch KG et al (2013) A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend 133:94\u201399. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.05.026","journal-title":"Drug Alcohol Depend"},{"key":"303_CR107","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","volume":"155","author":"KM Kampman","year":"2015","unstructured":"Kampman KM, Lynch KG, Pettinati HM et al (2015) A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend 155:105\u2013110. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.005","journal-title":"Drug Alcohol Depend"},{"key":"303_CR108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.06.020","volume":"166","author":"AN Karkhanis","year":"2016","unstructured":"Karkhanis AN, Beveridge TJR, Blough BE et al (2016) The individual and combined effects of phenmetrazine and mgluR2\/3 agonist LY379268 on the motivation to self-administer cocaine. Drug Alcohol Depend 166:51\u201360. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.06.020","journal-title":"Drug Alcohol Depend"},{"key":"303_CR109","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0740-5472(84)90033-3","volume":"1","author":"EJ Khantzian","year":"1984","unstructured":"Khantzian EJ, Gawin F, Kleber HD, Riordan CE (1984) Methylphenidate (Ritalin\u00ae) treatment of cocaine dependence \u2013 a preliminary report. J Subst Abuse Treat 1:107\u2013112. https:\/\/doi.org\/10.1016\/0740-5472(84)90033-3","journal-title":"J Subst Abuse Treat"},{"key":"303_CR110","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/npp.2015.193","volume":"41","author":"H Kober","year":"2016","unstructured":"Kober H, Lacadie CM, Wexler BE et al (2016) Brain activity during cocaine craving and gambling urges: an fMRI study. Neuropsychopharmacology 41:628\u2013637. https:\/\/doi.org\/10.1038\/npp.2015.193","journal-title":"Neuropsychopharmacology"},{"key":"303_CR111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0740-5472(93)90100-G","volume":"10","author":"TA Kosten","year":"1993","unstructured":"Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ (1993) Gender differences in cocaine use and treatment response. J Subst Abuse Treat 10:63\u201366","journal-title":"J Subst Abuse Treat"},{"key":"303_CR112","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/sj.npp.1300851","volume":"31","author":"TR Kosten","year":"2006","unstructured":"Kosten TR, Scanley BE, Tucker KA et al (2006) Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31:644\u2013650. https:\/\/doi.org\/10.1038\/sj.npp.1300851","journal-title":"Neuropsychopharmacology"},{"key":"303_CR113","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1530-0277.2009.00913.x","volume":"33","author":"HR Kranzler","year":"2009","unstructured":"Kranzler HR, Gelernter J, Anton RF et al (2009) Association of markers in the 3\u2032 region of the GluR5 kainate receptor subunit gene to alcohol dependence. Alcohol Clin Exp Res 33:925\u2013930. https:\/\/doi.org\/10.1111\/j.1530-0277.2009.00913.x","journal-title":"Alcohol Clin Exp Res"},{"key":"303_CR114","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1111\/acer.12578","volume":"38","author":"HR Kranzler","year":"2014","unstructured":"Kranzler HR, Wetherill R, Feinn R et al (2014) Posttreatment effects of topiramate treatment for heavy drinking. Alcohol Clin Exp Res 38:3017\u20133023. https:\/\/doi.org\/10.1111\/acer.12578","journal-title":"Alcohol Clin Exp Res"},{"key":"303_CR115","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1460-9568.2010.07590.x","volume":"33","author":"S K\u00fchn","year":"2011","unstructured":"K\u00fchn S, Gallinat J (2011) Common biology of craving across legal and illegal drugs \u2013 a quantitative meta-analysis of cue-reactivity brain response. Eur J Neurosci 33:1318\u20131326. https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07590.x","journal-title":"Eur J Neurosci"},{"key":"303_CR116","first-page":"797","volume":"290","author":"SA Kushner","year":"1999","unstructured":"Kushner SA, Dewey SL, Kornetsky C (1999) The irreversible \u03b3-aminobutyric acid (GABA) transaminase inhibitor \u03b3-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797\u2013802","journal-title":"J Pharmacol Exp Ther"},{"key":"303_CR117","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1124\/jpet.108.149773","volume":"330","author":"R Lal","year":"2009","unstructured":"Lal R, Sukbuntherng J, Tai EHL et al (2009) Arbaclofen placarbil, a novel r-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen. J Pharmacol Exp Ther 330:911\u2013921. https:\/\/doi.org\/10.1124\/jpet.108.149773","journal-title":"J Pharmacol Exp Ther"},{"key":"303_CR118","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.drugalcdep.2012.08.018","volume":"128","author":"SCB Lam","year":"2013","unstructured":"Lam SCB, Wang Z, Li Y et al (2013) Wavelet-transformed temporal cerebral blood flow signals during attempted inhibition of cue-induced cocaine craving distinguish prognostic phenotypes. Drug Alcohol Depend 128:140\u2013147. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.08.018","journal-title":"Drug Alcohol Depend"},{"key":"303_CR119","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1176\/appi.ajp.2007.07010070","volume":"165","author":"DD Langleben","year":"2008","unstructured":"Langleben DD, Ruparel K, Elman I et al (2008) Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues. Am J Psychiatry 165:390\u2013394. https:\/\/doi.org\/10.1176\/appi.ajp.2007.07010070","journal-title":"Am J Psychiatry"},{"key":"303_CR120","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/npp.2015.177","volume":"41","author":"B Le Foll","year":"2016","unstructured":"Le Foll B, Payer D, Di Ciano P et al (2016) Occupancy of dopamine D3 and D2 receptors by buspirone: a [11C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 41:529\u2013537. https:\/\/doi.org\/10.1038\/npp.2015.177","journal-title":"Neuropsychopharmacology"},{"key":"303_CR121","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4088\/JCP.v59n0605","volume":"59","author":"FR Levin","year":"1998","unstructured":"Levin FR, Evans SM, McDowell DM, Kleber HD (1998) Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder: a pilot study. J Clin Psychiatry 59:300\u2013305","journal-title":"J Clin Psychiatry"},{"key":"303_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/15504260802628767","volume":"5","author":"FR Levin","year":"2009","unstructured":"Levin FR, Mariani JJ, Secora A et al (2009) Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial. J Dual Diagn 5:41\u201356. https:\/\/doi.org\/10.1080\/15504260802628767","journal-title":"J Dual Diagn"},{"key":"303_CR123","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","volume":"72","author":"FR Levin","year":"2015","unstructured":"Levin FR, Mariani JJ, Specker S et al (2015) Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder. JAMA Psychiat 72:593\u2013602. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.41","journal-title":"JAMA Psychiat"},{"key":"303_CR124","doi-asserted-by":"publisher","first-page":"107700","DOI":"10.1016\/j.drugalcdep.2019.107700","volume":"206","author":"Frances R. Levin","year":"2020","unstructured":"Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K (2020) Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug Alcohol Depend 206:107700","journal-title":"Drug and Alcohol Dependence"},{"key":"303_CR125","doi-asserted-by":"publisher","first-page":"14455","DOI":"10.1073\/pnas.1002467107","volume":"107","author":"CR Li","year":"2010","unstructured":"Li CR, Morgan PT, Matuskey D et al (2010) Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proc Natl Acad Sci U S A 107:14455\u201314459. https:\/\/doi.org\/10.1073\/pnas.1002467107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"303_CR126","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/adb.12182","volume":"20","author":"Q Li","year":"2015","unstructured":"Li Q, Li W, Wang H et al (2015) Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: an event-related functional magnetic resonance imaging study. Addict Biol 20:968\u2013978. https:\/\/doi.org\/10.1111\/adb.12182","journal-title":"Addict Biol"},{"key":"303_CR127","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0893-133X(97)00128-0","volume":"18","author":"W Ling","year":"1998","unstructured":"Ling W, Shoptaw S, Majewska D (1998) Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18:403\u2013404. https:\/\/doi.org\/10.1016\/S0893-133X(97)00128-0","journal-title":"Neuropsychopharmacology"},{"key":"303_CR128","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2165\/11587790-000000000-00000","volume":"25","author":"ML Logrip","year":"2011","unstructured":"Logrip ML, Koob GF, Zorrilla EP (2011) Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 25:271\u2013287. https:\/\/doi.org\/10.2165\/11587790-000000000-00000","journal-title":"CNS Drugs"},{"key":"303_CR129","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/mp.2011.114","volume":"17","author":"J Luigjes","year":"2012","unstructured":"Luigjes J, van den Brink W, Feenstra M et al (2012) Deep brain stimulation in addiction: a review of potential brain targets. Mol Psychiatry 17:572\u2013583. https:\/\/doi.org\/10.1038\/mp.2011.114","journal-title":"Mol Psychiatry"},{"key":"303_CR130","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40263-018-0596-3","volume":"33","author":"P Maccioni","year":"2019","unstructured":"Maccioni P, Colombo G (2019) Potential of GABAB receptor positive allosteric modulators in the treatment of alcohol use disorder. CNS Drugs 33:107\u2013123. https:\/\/doi.org\/10.1007\/s40263-018-0596-3","journal-title":"CNS Drugs"},{"key":"303_CR131","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/syn.20891","volume":"65","author":"RH Mach","year":"2011","unstructured":"Mach RH, Tu Z, Xu J et al (2011) Endogenous dopamine competes with the binding of a radiolabeled D3 receptor partial agonist in vivo: a positron emission tomography study. Synapse 65:724\u2013732. https:\/\/doi.org\/10.1002\/syn.20891","journal-title":"Synapse"},{"issue":"8","key":"303_CR132","doi-asserted-by":"publisher","first-page":"e186466","DOI":"10.1001\/jamanetworkopen.2018.6466","volume":"1","author":"Kelly H. MacNiven","year":"2018","unstructured":"MacNiven KH, Jensen ELS, Borg N et al (2018) Association of neural responses to drug cues with subsequent relapse to stimulant use. JAMA Netw Open 1:e186466. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6466","journal-title":"JAMA Network Open"},{"key":"303_CR133","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","volume":"51","author":"MJ Maguire","year":"2010","unstructured":"Maguire MJ, Hemming K, Wild JM et al (2010) Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 51:2423\u20132431. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02772.x","journal-title":"Epilepsia"},{"key":"303_CR134","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1111\/acer.12546","volume":"38","author":"K Mann","year":"2014","unstructured":"Mann K, Vollst\u00e4dt-Klein S, Reinhard I et al (2014) Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging. Alcohol Clin Exp Res 38:2754\u20132762. https:\/\/doi.org\/10.1111\/acer.12546","journal-title":"Alcohol Clin Exp Res"},{"key":"303_CR135","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.psc.2012.03.012","volume":"35","author":"JJ Mariani","year":"2012","unstructured":"Mariani JJ, Levin FR (2012) Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am 35:425\u2013439. https:\/\/doi.org\/10.1016\/j.psc.2012.03.012","journal-title":"Psychiatr Clin North Am"},{"key":"303_CR136","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/acer.12235","volume":"38","author":"A Marsot","year":"2014","unstructured":"Marsot A, Imbert B, Alvarez J-C et al (2014) High variability in the exposure of baclofen in alcohol-dependent patients. Alcohol Clin Exp Res 38:316\u2013321. https:\/\/doi.org\/10.1111\/acer.12235","journal-title":"Alcohol Clin Exp Res"},{"key":"303_CR137","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1176\/appi.ajp.2009.08121801","volume":"166","author":"D Martinez","year":"2009","unstructured":"Martinez D, Greene K, Broft A et al (2009) Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D 2\/D 3 receptors following acute dopamine depletion. Am J Psychiatry 166:1170\u20131177. https:\/\/doi.org\/10.1176\/appi.ajp.2009.08121801","journal-title":"Am J Psychiatry"},{"key":"303_CR138","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1176\/appi.ajp.2010.10050748","volume":"168","author":"D Martinez","year":"2011","unstructured":"Martinez D, Carpenter KM, Liu F et al (2011) Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry 168:634\u2013641. https:\/\/doi.org\/10.1176\/appi.ajp.2010.10050748","journal-title":"Am J Psychiatry"},{"key":"303_CR139","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1523\/JNEUROSCI.21-21-08655.2001","volume":"21","author":"K McFarland","year":"2001","unstructured":"McFarland K, Kalivas PW (2001) The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655\u20138663. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-21-08655.2001","journal-title":"J Neurosci"},{"key":"303_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/ADA-120001278","volume":"28","author":"MA Medrano","year":"2002","unstructured":"Medrano MA, Hatch JP, Zule WA, Desmond DP (2002) Psychological distress in childhood trauma survivors who abuse drugs. Am J Drug Alcohol Abuse 28:1\u201313","journal-title":"Am J Drug Alcohol Abuse"},{"key":"303_CR141","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pnpbp.2017.03.003","volume":"80","author":"SJ Moeller","year":"2018","unstructured":"Moeller SJ, Paulus MP (2018) Toward biomarkers of the addicted human brain: using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Prog Neuropsychopharmacol Biol Psychiatry 80:143\u2013154. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.03.003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"303_CR142","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.10.011","volume":"88","author":"ME Mooney","year":"2007","unstructured":"Mooney ME, Schmitz JM, Moeller FG, Grabowski J (2007) Safety, tolerability and efficacy of levodopa\u2013carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials. Drug Alcohol Depend 88:214\u2013223. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.10.011","journal-title":"Drug Alcohol Depend"},{"issue":"21","key":"303_CR500","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1007\/s00213-014-3555-9","volume":"231","author":"Megan M. Moran-Santa Maria","year":"2014","unstructured":"Moran-Santa Maria MM, McRae-Clark A, Baker NL, Ramakrishnan V, Brady KT (2014) Yohimbine administration and cue-reactivity in cocaine-dependent individuals. Psychopharmacology (Berl) 231:4157\u20134165","journal-title":"Psychopharmacology"},{"key":"303_CR143","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<60::AID-SYN7>3.0.CO;2-A","volume":"28","author":"AE Morgan","year":"1998","unstructured":"Morgan AE, Dewey SL (1998) Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60\u201365. https:\/\/doi.org\/10.1002\/(SICI)1098-2396(199801)28:1<60::AID-SYN7>3.0.CO;2-A","journal-title":"Synapse"},{"key":"303_CR144","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.drugalcdep.2015.12.004","volume":"160","author":"PT Morgan","year":"2016","unstructured":"Morgan PT, Angarita GA, Canavan S et al (2016) Modafinil and sleep architecture in an inpatient\u2013outpatient treatment study of cocaine dependence. Drug Alcohol Depend 160:49\u201356. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.004","journal-title":"Drug Alcohol Depend"},{"key":"303_CR145","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/add.14373","volume":"113","author":"KC Morley","year":"2018","unstructured":"Morley KC, Luquin N, Baillie A et al (2018) Moderation of baclofen response by a GABAB receptor polymorphism: results from the BacALD randomized controlled trial. Addiction 113:2205\u20132213. https:\/\/doi.org\/10.1111\/add.14373","journal-title":"Addiction"},{"key":"303_CR146","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/npp.2014.322","volume":"40","author":"SS Negus","year":"2015","unstructured":"Negus SS, Henningfield J (2015) Agonist medications for the treatment of cocaine use disorder. Neuropsychopharmacology 40:1815\u20131825. https:\/\/doi.org\/10.1038\/npp.2014.322","journal-title":"Neuropsychopharmacology"},{"key":"303_CR147","volume-title":"Emerging threats report 2018: status and factors affecting the United States","author":"NETI","year":"2018","unstructured":"NETI (2018) Emerging threats report 2018: status and factors affecting the United States. National Drug Control Policy, High Intensity Drug Trafficking Areas, National Emerging Threats Initiative, Washington"},{"key":"303_CR148","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-244X-11-135","volume":"11","author":"M Nuijten","year":"2011","unstructured":"Nuijten M, Blanken P, van den Brink W, Hendriks V (2011) Cocaine addiction treatments to improve control and reduce harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands. BMC Psychiatry 11:135. https:\/\/doi.org\/10.1186\/1471-244X-11-135","journal-title":"BMC Psychiatry"},{"key":"303_CR149","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","volume":"387","author":"M Nuijten","year":"2016","unstructured":"Nuijten M, Blanken P, van de Wetering B et al (2016) Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. Lancet 387:2226\u20132234. https:\/\/doi.org\/10.1016\/S0140-6736(16)00205-1","journal-title":"Lancet"},{"key":"303_CR150","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1001\/jamapsychiatry.2016.2181","volume":"73","author":"MA Parvaz","year":"2016","unstructured":"Parvaz MA, Moeller SJ, Goldstein RZ (2016) Incubation of cue-induced craving in adults addicted to cocaine measured by electroencephalography. JAMA Psychiat 73:1127\u20131134. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.2181","journal-title":"JAMA Psychiat"},{"key":"303_CR151","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0740-5472(02)00237-4","volume":"23","author":"AA Patkar","year":"2002","unstructured":"Patkar AA, Thornton CC, Berrettini WH et al (2002) Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures. J Subst Abuse Treat 23:33\u201340","journal-title":"J Subst Abuse Treat"},{"key":"303_CR152","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874473711003010049","volume":"3","author":"JK Penberthy","year":"2010","unstructured":"Penberthy JK, Ait-Daoud N, Vaughan M, Fanning T (2010) Review of treatment for cocaine dependence. Curr Drug Abuse Rev 3:49\u201362","journal-title":"Curr Drug Abuse Rev"},{"key":"303_CR153","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jsat.2007.05.011","volume":"34","author":"HM Pettinati","year":"2008","unstructured":"Pettinati HM, Kampman KM, Lynch KG et al (2008) Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat 34:378\u2013390. https:\/\/doi.org\/10.1016\/j.jsat.2007.05.011","journal-title":"J Subst Abuse Treat"},{"key":"303_CR154","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1111\/ejn.12733","volume":"40","author":"KA Pitman","year":"2014","unstructured":"Pitman KA, Puil E, Borgland SL (2014) GABAB modulation of dopamine release in the nucleus accumbens core. Eur J Neurosci 40:3472\u20133480. https:\/\/doi.org\/10.1111\/ejn.12733","journal-title":"Eur J Neurosci"},{"key":"303_CR155","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/npp.2017.156","volume":"43","author":"AP Prescot","year":"2018","unstructured":"Prescot AP, Miller SR, Ingenito G et al (2018) In vivo detection of CPP-115 target engagement in human brain. Neuropsychopharmacology 43:646\u2013654. https:\/\/doi.org\/10.1038\/npp.2017.156","journal-title":"Neuropsychopharmacology"},{"key":"303_CR156","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00213-008-1122-y","volume":"200","author":"VA Redila","year":"2008","unstructured":"Redila VA, Chavkin C (2008) Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) 200:59\u201370. https:\/\/doi.org\/10.1007\/s00213-008-1122-y","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"303_CR157","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/adb.12445","volume":"22","author":"PS Regier","year":"2016","unstructured":"Regier PS, Monge ZA, Franklin TR et al (2016) Emotional, physical and sexual abuse are associated with a heightened limbic response to cocaine cues. Addict Biol 22(6):1768\u20131777. https:\/\/doi.org\/10.1111\/adb.12445","journal-title":"Addict Biol"},{"key":"303_CR158","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15288\/jsa.2001.62.114","volume":"62","author":"C Rice","year":"2001","unstructured":"Rice C, Mohr CD, Del Boca FK et al (2001) Self-reports of physical, sexual and emotional abuse in an alcoholism treatment sample. J Stud Alcohol 62:114\u2013123","journal-title":"J Stud Alcohol"},{"key":"303_CR159","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0893-133X(96)00002-4","volume":"15","author":"DC Roberts","year":"1996","unstructured":"Roberts DC, Andrews MM, Vickers GJ (1996) Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15:417\u2013423. https:\/\/doi.org\/10.1016\/0893-133X(96)00002-4","journal-title":"Neuropsychopharmacology"},{"key":"303_CR160","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","volume":"96","author":"TE Robinson","year":"2001","unstructured":"Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103\u2013114. https:\/\/doi.org\/10.1046\/j.1360-0443.2001.9611038.x","journal-title":"Addiction"},{"key":"303_CR161","volume-title":"Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health","author":"SAMHSA","year":"2018","unstructured":"SAMHSA (2018) Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville"},{"key":"303_CR162","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1017\/S146114571300045X","volume":"16","author":"J Savitz","year":"2013","unstructured":"Savitz J, Hodgkinson CA, Martin-Soelch C et al (2013) DRD2\/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2\/3 receptor binding in healthy controls and patients with major depressive disorder. Int J Neuropsychopharmacol 16:2095\u20132101. https:\/\/doi.org\/10.1017\/S146114571300045X","journal-title":"Int J Neuropsychopharmacol"},{"key":"303_CR163","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0893-133X(01)00268-8","volume":"25","author":"WK Schiffer","year":"2001","unstructured":"Schiffer WK, Gerasimov M, Hofmann L et al (2001a) Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. Neuropsychopharmacology 25:704\u2013712. https:\/\/doi.org\/10.1016\/S0893-133X(01)00268-8","journal-title":"Neuropsychopharmacology"},{"key":"303_CR164","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/syn.10000","volume":"42","author":"WK Schiffer","year":"2001","unstructured":"Schiffer WK, Gerasimov MR, Marsteller DA et al (2001b) Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 42:196\u2013198. https:\/\/doi.org\/10.1002\/syn.10000","journal-title":"Synapse"},{"key":"303_CR165","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","volume":"94","author":"JM Schmitz","year":"2008","unstructured":"Schmitz JM, Mooney ME, Moeller FG et al (2008) Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend 94:142\u2013150. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.11.004","journal-title":"Drug Alcohol Depend"},{"key":"303_CR166","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/a0019195","volume":"18","author":"JM Schmitz","year":"2010","unstructured":"Schmitz JM, Lindsay JA, Stotts AL et al (2010) Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets. Exp Clin Psychopharmacol 18:238\u2013244. https:\/\/doi.org\/10.1037\/a0019195","journal-title":"Exp Clin Psychopharmacol"},{"key":"303_CR167","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fpsyt.2012.00077","volume":"3","author":"JM Schmitz","year":"2012","unstructured":"Schmitz JM, Rathnayaka N, Green CE et al (2012) Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation. Front Psychiatry 3:77. https:\/\/doi.org\/10.3389\/fpsyt.2012.00077","journal-title":"Front Psychiatry"},{"key":"303_CR168","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","volume":"10","author":"H Schubiner","year":"2002","unstructured":"Schubiner H, Saules KK, Arfken CL et al (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10:286\u2013294","journal-title":"Exp Clin Psychopharmacol"},{"key":"303_CR169","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0006-8993(92)90672-V","volume":"571","author":"DS Segal","year":"1992","unstructured":"Segal DS, Kuczenski R (1992a) In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 571:330\u2013337","journal-title":"Brain Res"},{"key":"303_CR170","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0006-8993(92)90297-M","volume":"577","author":"DS Segal","year":"1992","unstructured":"Segal DS, Kuczenski R (1992b) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res 577:351\u2013355","journal-title":"Brain Res"},{"key":"303_CR171","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","volume":"98","author":"J Shearer","year":"2003","unstructured":"Shearer J, Wodak A, Beek IV et al (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98:1137\u20131141. https:\/\/doi.org\/10.1046\/j.1360-0443.2003.00447.x","journal-title":"Addiction"},{"key":"303_CR172","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4088\/JCP.08r04062gry","volume":"71","author":"AK Shinn","year":"2010","unstructured":"Shinn AK, Greenfield SF (2010) Topiramate in the treatment of substance related disorders: a critical review of the literature. J Clin Psychiatry 71:634\u2013648. https:\/\/doi.org\/10.4088\/JCP.08r04062gry","journal-title":"J Clin Psychiatry"},{"key":"303_CR173","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.4088\/JCP.v64n1207","volume":"64","author":"S Shoptaw","year":"2003","unstructured":"Shoptaw S, Yang X, Rotheram-Fuller EJ et al (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64:1440\u20131448","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"303_CR174","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1360-0443.2005.00991.x","volume":"100","author":"S Shoptaw","year":"2005","unstructured":"Shoptaw S, Watson DW, Reiber C et al (2005) Randomized controlled pilot trial of cabergoline, hydergine and levodopa\/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST). Addiction 100(Suppl 1):78\u201390. https:\/\/doi.org\/10.1111\/j.1360-0443.2005.00991.x","journal-title":"Addiction"},{"key":"303_CR175","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1741-7015-9-119","volume":"9","author":"D Shorter","year":"2011","unstructured":"Shorter D, Kosten TR (2011) Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med 9:119. https:\/\/doi.org\/10.1186\/1741-7015-9-119","journal-title":"BMC Med"},{"issue":"11","key":"303_CR176","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.euroneuro.2013.05.014","volume":"23","author":"D Shorter","year":"2013","unstructured":"Shorter D, Nielsen DA, Huang W et al (2013) Pharmacogenetic randomized trial for cocaine abuse: disulfiram and \u03b11A-adrenoceptor gene variation. Eur Neuropsychopharmacol 23(11):1401\u20131407. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.014","journal-title":"Eur Neuropsychopharmacol"},{"key":"303_CR177","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14728214.2015.985203","volume":"20","author":"D Shorter","year":"2015","unstructured":"Shorter D, Domingo CB, Kosten TR (2015) Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opin Emerg Drugs 20:15\u201329. https:\/\/doi.org\/10.1517\/14728214.2015.985203","journal-title":"Expert Opin Emerg Drugs"},{"key":"303_CR178","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s002130100917","volume":"158","author":"R Sinha","year":"2001","unstructured":"Sinha R (2001) How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 158:343\u2013359. https:\/\/doi.org\/10.1007\/s002130100917","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR179","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1196\/annals.1441.030","volume":"1141","author":"R Sinha","year":"2008","unstructured":"Sinha R (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141:105\u2013130. https:\/\/doi.org\/10.1196\/annals.1441.030","journal-title":"Ann N Y Acad Sci"},{"key":"303_CR180","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00213-005-0147-8","volume":"183","author":"R Sinha","year":"2005","unstructured":"Sinha R, Lacadie C, Skudlarski P et al (2005) Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 183:171\u2013180. https:\/\/doi.org\/10.1007\/s00213-005-0147-8","journal-title":"Psychopharmacology (Berl)"},{"key":"303_CR181","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/npp.2008.78","volume":"34","author":"R Sinha","year":"2009","unstructured":"Sinha R, Fox HC, Hong KA et al (2009) Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34:1198\u20131208. https:\/\/doi.org\/10.1038\/npp.2008.78","journal-title":"Neuropsychopharmacology"},{"key":"303_CR182","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1570159X13666150729222643","volume":"13","author":"A Siniscalchi","year":"2015","unstructured":"Siniscalchi A, Bonci A, Biagio Mercuri N et al (2015) The role of topiramate in the management of cocaine addiction: a possible therapeutic option. Curr Neuropharmacol 13:815\u2013818","journal-title":"Curr Neuropharmacol"},{"key":"303_CR183","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamapsychiatry.2013.872","volume":"70","author":"EC Somoza","year":"2013","unstructured":"Somoza EC, Winship D, Gorodetzky CW et al (2013) A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence. JAMA Psychiat 70:630\u2013637. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.872","journal-title":"JAMA Psychiat"},{"key":"303_CR184","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1586\/17512433.2014.909283","volume":"7","author":"WW Stoops","year":"2014","unstructured":"Stoops WW, Rush CR (2014) Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research. Expert Rev Clin Pharmacol 7:363\u2013374. https:\/\/doi.org\/10.1586\/17512433.2014.909283","journal-title":"Expert Rev Clin Pharmacol"},{"key":"303_CR185","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/10550490802409074","volume":"17","author":"JJ Suh","year":"2008","unstructured":"Suh JJ, Pettinati HM, Kampman KM, O\u2019Brien CP (2008) Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence. Am J Addict 17:463\u2013468. https:\/\/doi.org\/10.1080\/10550490802409074","journal-title":"Am J Addict"},{"key":"303_CR186","volume-title":"World drug report 2018","author":"UNODC","year":"2018","unstructured":"UNODC (2018) World drug report 2018. United Nations Office on Drugs and Crime, Vienna"},{"key":"303_CR187","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/npp.2016.237","volume":"42","author":"J Veenstra-VanderWeele","year":"2017","unstructured":"Veenstra-VanderWeele J, Cook EH, King BH et al (2017) Arbaclofen in children and adolescents with autism spectrum disorder: a randomized, controlled, phase 2 trial. Neuropsychopharmacology 42:1390\u20131398. https:\/\/doi.org\/10.1038\/npp.2016.237","journal-title":"Neuropsychopharmacology"},{"key":"303_CR188","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","volume":"141","author":"CD Verrico","year":"2014","unstructured":"Verrico CD, Haile CN, Mahoney JJ et al (2014) Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend 141:72\u201378. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.008","journal-title":"Drug Alcohol Depend"},{"key":"303_CR189","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1503\/jpn.130027","volume":"39","author":"TW Viola","year":"2014","unstructured":"Viola TW, Tractenberg SG, Levandowski ML et al (2014) Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress. J Psychiatry Neurosci 39:206\u2013214. https:\/\/doi.org\/10.1503\/jpn.130027","journal-title":"J Psychiatry Neurosci"},{"key":"303_CR190","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","volume":"26","author":"ND Volkow","year":"2006","unstructured":"Volkow ND, Wang G-J, Telang F et al (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26:6583\u20136588. https:\/\/doi.org\/10.1523\/JNEUROSCI.1544-06.2006","journal-title":"J Neurosci"},{"key":"303_CR191","doi-asserted-by":"publisher","first-page":"e68791","DOI":"10.1371\/journal.pone.0068791","volume":"8","author":"G Wang","year":"2013","unstructured":"Wang G, Shi J, Chen N et al (2013) Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS One 8:e68791. https:\/\/doi.org\/10.1371\/journal.pone.0068791","journal-title":"PLoS One"},{"key":"303_CR192","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.drugalcdep.2006.12.023","volume":"89","author":"EM Weerts","year":"2007","unstructured":"Weerts EM, Froestl W, Kaminski BJ, Griffiths RR (2007) Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend 89:206\u2013213. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.12.023","journal-title":"Drug Alcohol Depend"},{"key":"303_CR193","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.158.1.86","volume":"158","author":"BE Wexler","year":"2001","unstructured":"Wexler BE, Gottschalk CH, Fulbright RK et al (2001) Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 158:86\u201395. https:\/\/doi.org\/10.1176\/appi.ajp.158.1.86","journal-title":"Am J Psychiatry"},{"key":"303_CR194","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nn.3694","volume":"17","author":"I Willuhn","year":"2014","unstructured":"Willuhn I, Burgeno LM, Groblewski PA, Phillips PEM (2014) Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat Neurosci 17:704\u2013709. https:\/\/doi.org\/10.1038\/nn.3694","journal-title":"Nat Neurosci"},{"key":"303_CR195","first-page":"440","volume":"10","author":"R Wolfsohn","year":"1990","unstructured":"Wolfsohn R, Angrist B (1990) A pilot trial of levodopa\/carbidopa in early cocaine abstinence. J Clin Psychopharmacol 10:440\u2013442","journal-title":"J Clin Psychopharmacol"},{"key":"303_CR196","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/npp.1993.42","volume":"9","author":"R Wolfsohn","year":"1993","unstructured":"Wolfsohn R, Sanfilipo M, Angrist B (1993) A placebo-controlled trial of L-dopa\/carbidopa in early cocaine abstinence. Neuropsychopharmacology 9:49\u201353. https:\/\/doi.org\/10.1038\/npp.1993.42","journal-title":"Neuropsychopharmacology"},{"key":"303_CR197","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1038\/sj.npp.1301194","volume":"31","author":"DF Wong","year":"2006","unstructured":"Wong DF, Kuwabara H, Schretlen DJ et al (2006) Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31:2716\u20132727. https:\/\/doi.org\/10.1038\/sj.npp.1301194","journal-title":"Neuropsychopharmacology"},{"key":"303_CR198","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1523\/JNEUROSCI.4977-13.2014","volume":"34","author":"KA Young","year":"2014","unstructured":"Young KA, Franklin TR, Roberts DCS et al (2014) Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues. J Neurosci 34:5038\u20135043. https:\/\/doi.org\/10.1523\/JNEUROSCI.4977-13.2014","journal-title":"J Neurosci"}],"container-title":["Handbook of Experimental Pharmacology","Substance Use Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T01:42:12Z","timestamp":1614908532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030336783","9783030336790"],"references-count":199,"URL":"https:\/\/doi.org\/10.1007\/164_2019_303","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"20 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}